Literature DB >> 16937461

Etiopathogenesis of inflammatory bowel diseases.

Silvio Danese1, Claudio Fiocchi.   

Abstract

Theories explaining the etiopathogenesis of inflammatory bowel disease (IBD) have been proposed ever since Crohn's disease (CD) and ulcerative colitis (UC) were recognized as the two major forms of the disease. Although the exact cause(s) and mechanisms of tissue damage in CD and UC have yet to be completely understood, enough progress has occurred to accept the following hypothesis as valid: IBD is an inappropriate immune response that occurs in genetically susceptible individuals as the result of a complex interaction among environmental factors, microbial factors, and the intestinal immune system. Among an almost endless list of environmental factors, smoking has been identified as a risk factor for CD and a protective factor for UC. Among microbial factors, no convincing evidence indicates that classical infectious agents cause IBD, while mounting evidence points to an abnormal immune response against the normal enteric flora as being of central importance. Gut inflammation is mediated by cells of the innate as well as adaptive immune systems, with the additional contribution of non-immune cells, such as epithelial, mesenchymal and endothelial cells, and platelets.

Entities:  

Mesh:

Year:  2006        PMID: 16937461      PMCID: PMC4087613          DOI: 10.3748/wjg.v12.i30.4807

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  70 in total

1.  Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn's disease.

Authors:  A Stallmach; D Schuppan; H H Riese; H Matthes; E O Riecken
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

2.  Matrix metalloproteinase levels are elevated in inflammatory bowel disease.

Authors:  M D Baugh; M J Perry; A P Hollander; D R Davies; S S Cross; A J Lobo; C J Taylor; G S Evans
Journal:  Gastroenterology       Date:  1999-10       Impact factor: 22.682

3.  Smoking habits and recurrence in Crohn's disease.

Authors:  M Cottone; M Rosselli; A Orlando; L Oliva; A Puleo; M Cappello; M Traina; F Tonelli; L Pagliaro
Journal:  Gastroenterology       Date:  1994-03       Impact factor: 22.682

4.  Non-smoking: a feature of ulcerative colitis.

Authors:  A D Harries; A Baird; J Rhodes
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-06

Review 5.  The emergence of inflammatory bowel disease in the Asian Pacific region.

Authors:  Qin Ouyang; Rakesh Tandon; Khean-Lee Goh; Choon Jin Ooi; Haruhiko Ogata; Claudio Fiocchi
Journal:  Curr Opin Gastroenterol       Date:  2005-07       Impact factor: 3.287

6.  Mucosal flora in inflammatory bowel disease.

Authors:  Alexander Swidsinski; Axel Ladhoff; Annelie Pernthaler; Sonja Swidsinski; Vera Loening-Baucke; Marianne Ortner; Jutta Weber; Uwe Hoffmann; Stefan Schreiber; Manfred Dietel; Herbert Lochs
Journal:  Gastroenterology       Date:  2002-01       Impact factor: 22.682

7.  Crohn's disease after in-utero measles virus exposure.

Authors:  A Ekbom; P Daszak; W Kraaz; A J Wakefield
Journal:  Lancet       Date:  1996-08-24       Impact factor: 79.321

8.  Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease.

Authors:  Stephan R Targan; Carol J Landers; Huiying Yang; Michael J Lodes; Yingzi Cong; Konstantinos A Papadakis; Eric Vasiliauskas; Charles O Elson; Robert M Hershberg
Journal:  Gastroenterology       Date:  2005-06       Impact factor: 22.682

Review 9.  Toll-like receptors in the pathogenesis of human disease.

Authors:  Donald N Cook; David S Pisetsky; David A Schwartz
Journal:  Nat Immunol       Date:  2004-10       Impact factor: 25.606

10.  Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)

Authors:  R Duchmann; I Kaiser; E Hermann; W Mayet; K Ewe; K H Meyer zum Büschenfelde
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

View more
  84 in total

Review 1.  Oral pathology in inflammatory bowel disease.

Authors:  Miranda Muhvić-Urek; Marija Tomac-Stojmenović; Brankica Mijandrušić-Sinčić
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

2.  Nanoparticle-based therapeutic delivery of prohibitin to the colonic epithelial cells ameliorates acute murine colitis.

Authors:  Arianne L Theiss; Hamed Laroui; Tracy S Obertone; Indrajit Chowdhury; Winston E Thompson; Didier Merlin; Shanthi V Sitaraman
Journal:  Inflamm Bowel Dis       Date:  2010-09-24       Impact factor: 5.325

3.  High incidence of inflammatory bowel disease with improved hygiene and failure to get human-like IBD in laboratory animals.

Authors:  Xiaofa Qin
Journal:  World J Gastroenterol       Date:  2007-06-21       Impact factor: 5.742

4.  No association of the cytotoxic T-lymphocyte associated gene CTLA4 +49A/G polymorphisms with Crohn's disease and ulcerative colitis in Hungarian population samples.

Authors:  Lili Magyari; Bernadett Faragó; Judit Bene; Katalin Horvatovich; Lilla Lakner; Márta Varga; Mária Figler; Beáta Gasztonyi; Gyula Mózsik; Béla Melegh
Journal:  World J Gastroenterol       Date:  2007-04-21       Impact factor: 5.742

Review 5.  Nutritional therapy for active Crohn's disease.

Authors:  Paul-A Smith
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

6.  Pharmacologic evaluation of sulfasalazine, FTY720, and anti-IL-12/23p40 in a TNBS-induced Crohn's disease model.

Authors:  Zaher A Radi; Deborah M Heuvelman; Jaime L Masferrer; Ericka L Benson
Journal:  Dig Dis Sci       Date:  2011-03-05       Impact factor: 3.199

7.  Immune response to influenza vaccine in children with inflammatory bowel disease.

Authors:  Ying Lu; Denise L Jacobson; Lori A Ashworth; Richard J Grand; Anthony L Meyer; Monica M McNeal; Matt C Gregas; Sandra K Burchett; Athos Bousvaros
Journal:  Am J Gastroenterol       Date:  2009-01-27       Impact factor: 10.864

8.  The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease?

Authors:  Justyna Bien; Vindhya Palagani; Przemyslaw Bozko
Journal:  Therap Adv Gastroenterol       Date:  2013-01       Impact factor: 4.409

Review 9.  Environmental triggers for inflammatory bowel disease.

Authors:  Ashwin N Ananthakrishnan
Journal:  Curr Gastroenterol Rep       Date:  2013-01

10.  Relationship and significance between anti-beta2-glycoprotein I antibodies and platelet activation state in patients with ulcerative colitis.

Authors:  Yan-Hang Gao; Pu-Jun Gao; Chun-Guang Wang; Xiao-Cong Wang; Yun-Feng Piao
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.